A phase 1/2, randomized, placebo controlled and open label extension studies of Givosiran and investigational RNA interference therapeutic, in patients with acute intermittent porphyria
Authors:
- E. SardhESE. Sardh
- M. BalwaniMBM. Balwani
- P. HarperPHP. Harper
- P. SteinPSP. Stein
- D. ReesDRD. Rees
- J. BloomerJBJ. Bloomer
- D.M. BissellDBD.M. Bissell
- C. ParketCPC. Parket
- J. PhillipsJPJ. Phillips
- H. BonkovskyHBH. Bonkovsky
- R. DesnickRDR. Desnick
- N. Al-TawilNAN. Al-Tawil
- 1 April 2018
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 68, S66-S67